📰 Operations Data News
Page 11 - Operations Data News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Operations Data. Real-time updates on events, politics, business and more.
July 19, 2023
Liberty Energy Inc., announced today second quarter 2023 financial and operational results. Summary Results and Highlights Revenue of $1.2 billion, a 27% increase over the prior year Net...
June 27, 2023
Results of the fourth quarter and fiscal 2023 included one additional week compared with the fourth quarter and fiscal 2022. All quarterly and annual...
June 27, 2023
Results of the fourth quarter and fiscal 2023 included one additional week compared with the fourth quarter and fiscal 2022. All quarterly and annual same-store information is presented on a comparable basis of 12 and 52 weeks, respectively.Fourth Quarter...
May 25, 2023
Born to Ethel and Robert J. Imrie in 1928, Aubrey Imrie grew up in Boston, Mass., and enlisted into the Armed Forces in 1945 after graduating from high school.
May 11, 2023
/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...
May 11, 2023
The Company is poised to commence Phase 3 for RZ358 in the third quarter of calendar year 2023REDWOOD CITY, Calif., May 11, 2023 -- Rezolute, Inc. , a clinical-stage biopharmaceutical company... | May 11, 2023
May 10, 2023
Presented positive interim data from intravitreal 4D-150 Phase 1/2 PRISM clinical trial for wet age-related macular degeneration at the 2023 ARVO Annual MeetingOn track for completion of enrollment... | May 10, 2023
May 9, 2023
Turkcell Iletisim Hizmetleri A.S. (NYSE:TKC) (BIST:TCELL): Please note that all financial data is consolidated and comprises that of Turkcell Iletisim Hizmetleri A.S. (the "Company", or "Turkcell")
May 8, 2023
08.05.2023 - ─ Tuspetinib Dose Escalation and Dose Exploration Trial Completed and Delivered Clinical Responses as Monotherapy Over Four Dose Levels in Very Difficult to Treat AML Patient Populations ─ ─ Doublet of Tuspetinib and Venetoclax Dosing Underway for ...
May 8, 2023
BASIS OF PRESENTATION This Managements Discussion and Analysis for Westport Fuel Systems Inc. for the three months ended March 31, 2023 provides an update to our annual... | May 8, 2023